Characterization of rhodopsin-transducin interaction: a mutant rhodopsin photoproduct with a protonated Schiff base activates transducin
- PMID: 8068654
- DOI: 10.1021/bi00198a046
Characterization of rhodopsin-transducin interaction: a mutant rhodopsin photoproduct with a protonated Schiff base activates transducin
Abstract
Rhodopsin, a G protein-coupled seven-transmembrane helix receptor, contains an 11-cis-retinal chromophore covalently linked to opsin apoprotein by a protonated Schiff base. Photoisomerization of the chromophore followed by Schiff base deprotonation forms metarhodopsin II (MII, lambda max = 380 nm), the active state (R*) that catalyzes guanine nucleotide exchange in transducin, the G protein of the photoreceptor cell. Schiff base deprotonation is required for R* formation. The Schiff base positive charge in rhodopsin is stabilized by a carboxylic acid counterion, Glu113. The position of the carboxylate counterion was moved by one helix turn to position 117 by site-specific mutagenesis. Photolysis of the mutant pigment E113A/A117E (lambda max = 491 nm) resulted in a mixture of two photoproducts: (1) an MII-like form with an unprotonated Schiff base (lambda max = 382 nm) favored at alkaline pH; and (2) a photoproduct with a protonated Schiff base (lambda max = 474 nm), spectroscopically similar to metarhodopsin I, favored at acidic pH. Here, we have studied the interactions between the mutant E113A/A117E photoproducts and transducin in detail. Transducin slowed down thermal conversion of the 474 nm form to the 382 nm form by stabilizing the 474 nm photoproduct. This effect was maximal at the pH optimum of transducin activation by the mutant R* and was abolished in the presence of GTP gamma S. In addition, the amount of the 474 nm species correlated with transducin activation rates during the thermal conversion of the photoproduct mixture. Thus, the 474 nm photoproduct of the mutant pigment, which contained a protonated Schiff base, activated transducin.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Movement of the retinylidene Schiff base counterion in rhodopsin by one helix turn reverses the pH dependence of the metarhodopsin I to metarhodopsin II transition.J Biol Chem. 1993 Mar 5;268(7):4661-7. J Biol Chem. 1993. PMID: 8444840
-
A mutant rhodopsin photoproduct with a protonated Schiff base displays an active-state conformation: a Fourier-transform infrared spectroscopy study.Biochemistry. 1994 Nov 22;33(46):13700-5. doi: 10.1021/bi00250a021. Biochemistry. 1994. PMID: 7947779
-
Light-dependent transducin activation by an ultraviolet-absorbing rhodopsin mutant.Biochemistry. 1993 Sep 7;32(35):9165-71. doi: 10.1021/bi00086a023. Biochemistry. 1993. PMID: 8396426
-
Interaction of rhodopsin with the G-protein, transducin.Bioessays. 1993 Jan;15(1):43-50. doi: 10.1002/bies.950150107. Bioessays. 1993. PMID: 8466475 Review.
-
Coupling of protonation switches during rhodopsin activation.Photochem Photobiol. 2007 Mar-Apr;83(2):286-92. doi: 10.1562/2006-06-19-IR-937. Photochem Photobiol. 2007. PMID: 17576345 Review.
Cited by
-
Prospectives for gene therapy of retinal degenerations.Curr Genomics. 2012 Aug;13(5):350-62. doi: 10.2174/138920212801619214. Curr Genomics. 2012. PMID: 23372421 Free PMC article.
-
Proton movement and photointermediate kinetics in rhodopsin mutants.Biochemistry. 2006 May 2;45(17):5430-9. doi: 10.1021/bi0525775. Biochemistry. 2006. PMID: 16634624 Free PMC article.
-
Constitutive activation of G protein-coupled receptors and diseases: insights into mechanisms of activation and therapeutics.Pharmacol Ther. 2008 Nov;120(2):129-48. doi: 10.1016/j.pharmthera.2008.07.005. Epub 2008 Aug 9. Pharmacol Ther. 2008. PMID: 18768149 Free PMC article. Review.
-
Relocating the active-site lysine in rhodopsin and implications for evolution of retinylidene proteins.Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):13351-5. doi: 10.1073/pnas.1306826110. Epub 2013 Jul 31. Proc Natl Acad Sci U S A. 2013. PMID: 23904486 Free PMC article.
-
Constitutive "light" adaptation in rods from G90D rhodopsin: a mechanism for human congenital nightblindness without rod cell loss.J Neurosci. 2001 Aug 1;21(15):5449-60. doi: 10.1523/JNEUROSCI.21-15-05449.2001. J Neurosci. 2001. PMID: 11466416 Free PMC article.